PubMed Health⌕ Search

Biomedical subjects

Beth Anne Biggee

Publications and source records attributed to Beth Anne Biggee.

3 recordsLinked to original sources

Nutritional factors and osteoarthritis: recent developments.

PURPOSE OF REVIEW: The role of nutrition and nutritional supplements in the development and progression of osteoarthritis is now a topic of considerable public, industry, and academic interest. This review focuses on how the evidence for a role of nutritional factors or nutritional supplements in the management of knee osteoarthritis has been changed by recent research. RECENT FINDINGS: Recent studies include clinical trials of weight loss and exercise as interventions for osteoarthritis of the knee, the elucidation of mechanisms of oxidative stress on the chondrocyte genome, further study of vitamin C supplementation in an animal with spontaneous osteoarthritis, and further clinical and pharmacodynamic evaluations of glucosamine and chondroitin sulfate. Perplexing findings among these studies include the deleterious effects of vitamin C on osteoarthritis in the Hartley guinea pig, the low levels of glucosamine achieved in serum after an oral dose, recent negative clinical studies of glucosamine, and the heterogeneity of results among glucosamine trials. SUMMARY: With an intensification of research in this field come new clinical and basic science data, sometimes with surprising results. These confirm the considerable potential for a role of nutritional interventions for osteoarthritis, but they emphasize the need for systematic scientific evaluation of the claims made for such products.

Animals↗

Glucosamine for osteoarthritis: part I, review of the clinical evidence.

Glucosamine is a popular nutritional supplement for OA. This supplement has shown moderate efficacy in meta-analysis and large industry-sponsored clinical trials. However, smaller independent studies have not shown significant benefit. It is difficult to compare these clinical trials due to heterogeneity in trial design, differences in glucosamine products, and differences in osteoarthritic populations being studied. The National Center for Complementary and Alternative Medicine and the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS/NCCAM) have funded a multicenter five arm placebo controlled study called The Glucosamine Arthritis Intervention Trial (GAIT). GAIT spans 24 weeks, enrolling 1588 subjects, at 13 centers comparing the efficacy of glucosamine sulfate, chondroitin sulfate, glucosamine with chondroitin, to placebo and compared to celecoxib for knee OA. This study may have final data in March 2005.

Clinical Trials as Topic↗

Glucosamine for osteoarthritis: part II, biologic and metabolic controversies.

Glucosamine is a popular nutritional supplement, discussed in clinical offices, peer-reviewed literature, and the media. Despite its popularity, much information is still needed regarding its biological effect in-vivo and its effects on glucose metabolism. The biologic effects of other constituents such as sulfate, chondroitin sulfate, and other additives need to be investigated as well.

Dietary Supplements↗